RACHEL FAIR: Open Payments
NPI 1376023937 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $65 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
Products named: VRAYLAR, FANAPT, SPRAVATO, CAPLYTA, TRINTELLIX, Auvelity, REXULTI, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
